Chief Scientific Officer · Q32 Bio Inc. (QTTB)

Shelia Violette

FY2025 is the first fiscal year CompBrief holds for Shelia Violette as a named executive officer of Q32 Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$774,446

Salary $455,000Stock awards $95,250

3rd of 3 named executive officers at Q32 Bio by FY2025 total.

3 named officers on file for Q32 Bio, FY2025

Shelia Violette’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Q32 Bio’s whole pay program stands against its peers

  • Q32 Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on QTTB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Shelia Violette’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Shelia Violette compensation by year

Q32 Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Q32 Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$455,000
Bonus$0
Stock awards$95,250
Option awards$37,312
Non-equity incentive$182,000
Pension and deferred compensation$0
All other$4,884
Total$774,446

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Q32 Bio Inc. DEF 14A filed April 30, 2026, accession 0001193125-26-193934, and prior-year filings.

How this page was built: the Q32 Bio Inc. filed document, accession 0001193125-26-193934. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU28,125$96,750—
Option31,733—$2.54

Per the Outstanding Equity Awards at Fiscal Year-End table in Q32 Bio Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2025 proxy (filed April 30, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-10-06Sale—917$8.32126,854
2026-08-25Sale—2,798$16.56127,771
2026-07-16Grant or award—37,500$0.00130,569

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Q32 Bio’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Jodie MorrisonChief Executive Officer and Director$1,558,870
Lee KalowskiChief Financial Officer and President$987,147
Shelia Violette · this pageChief Scientific Officer$774,446

The full Q32 Bio compensation record

free company brief

This page is one person within Q32 Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Q32 Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Shelia Violette's compensation dossier · One-time report. No refunds.